MedPath

Improving Negative Symptoms of Psychosis In Real-world Environments

Not Applicable
Completed
Conditions
Schizophrenia
Registration Number
NCT02170051
Lead Sponsor
University of California, San Diego
Brief Summary

This study will compare Cognitive Behavioral Social Skills Training-Compensatory Cognitive Training (CBSST-CCT) to a goal-focused supportive contact group to see which intervention better improves symptoms and functioning in people with schizophrenia.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
64
Inclusion Criteria

MUST BE A RESIDENT OF BROADWAY HOME, SAN DIEGO, OR A SERVICE USER OF THE MEETING PLACE, ARETA CROWELL, OR PROJECT ENABLE.

  1. Voluntary informed consent to participate
  2. Age 18 to 65
  3. DSM-IV diagnosis of schizophrenia or schizoaffective disorder based on MINI/SCID
  4. Moderate-to-severe negative symptoms on the Clinical Assessment Interview for Negative Symptoms (CAINS total score >19)
  5. ≥ 6th grade reading level on the Wide Range Achievement Test-4 Reading subtest (needed for reading treatment manual)
  6. Stable on medications; no changes within 3 months prior to enrollment
Exclusion Criteria
  1. Prior CBT, SST, or CCT in the past 5 years
  2. Severe positive symptoms on the Positive and Negative Syndrome Scale (PANSS Delusions, Disorganization, Hallucinations, or Suspiciousness >5)
  3. Severe depression on the Calgary Depression Scale for Schizophrenia (CDSS >8)
  4. Ocular damage/disease/surgery/medications that affect pupil dilation
  5. DSM-IV alcohol or substance dependence diagnosis in past 6 months based on the MINI or SCID
  6. Level of care required interferes with outpatient therapy (e.g., hospitalized; severe medical illness) .

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Clinical Assessment Interview for Negative Symptoms (CAINS)baseline, 12.5 weeks

Change in negative symptom severity at 12.5 weeks. Scores range from 0-52; higher values indicate greater severity.

Secondary Outcome Measures
NameTimeMethod
MATRICS Consensus Cognitive Battery (MCCB)baseline, 12.5 weeks

Change in cognitive performance in several domains at 12.5 weeks. Scores range from 0-80; higher scores indicate better performance.

UCSD Performance-based Skills Assessment-Brief (UPSA-B)baseline, 12.5 weeks

Change in communication and financial functioning at 12.5 weeks. Scores range from 0-100; higher scores indicate better performance.

Social Skills Performance Assessment (SSPA)baseline, 12.5 weeks

Change in social skills performance at 12.5 weeks. Scores range from 2-10; higher scores indicate better social skills.

Specific Levels of Functioning Scale (SLOF)baseline, 12.5 weeks

Change in self-reported functioning at 12.5 weeks. Scores range from 30-150. Higher score indicates better functioning.

Independent Living Skills Survey (ILSS)baseline, 12.5 weeks

Change in self-reported functioning at 12.5 weeks. Scores range from 0-1; higher score indicates better skills.

Defeatist Performance Attitudes Scale (DPAS)baseline, 12.5 weeks

Change in defeatist attitudes at 12.5 weeks. Likert Scale 1-7; scores range from 15-105; higher scores indicate a more severe defeatist performance attitude.

Scale for the Assessment of Negative Symptoms (SANS)baseline, 12.5 weeks

Change in negative symptom severity at 12.5 weeks. Scores range from 0-25; higher values indicate greater severity.

Trial Locations

Locations (1)

UCSD

🇺🇸

La Jolla, California, United States

UCSD
🇺🇸La Jolla, California, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.